|
Scores
Hi George,
As far as I understand both IPSS and WPSS give figures in patient materials up to 2004 or earlier. That means that only patients in trials were treated for example with Vidaza/Dacogen or Revlimid. Few patients got drugs for iron over load and drugs like Neupogen. When I looked at the WPSS median survival for me the median increased from 19 months to 31 months in a more up to date article.
Then there are several groups that have their own prognostic variables. When they look at for example performance status and comorbidity (other diseases) I get a better median survival becuse I feel OK.
Kind regards
Birgitta-A
69 yo, transfusion dependent, Desferal for iron over load, Neupogen for low white blood cells, asymptomatic
|